| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/15/2013 | CA2424607C Use of probiotic lactic acid bacteria for balancing the skin's immune system |
| 01/15/2013 | CA2406725C Edg8 receptor, its preparation and use |
| 01/15/2013 | CA2400842C Novel compounds |
| 01/10/2013 | WO2013005834A1 Anti-obesity agent comprising high-purity epa |
| 01/10/2013 | WO2013005760A1 Adhesive skin patch containing serotonin receptor antagonist drug |
| 01/10/2013 | WO2013004766A1 Nk-1 receptor antagonists for treating corneal neovascularisation |
| 01/10/2013 | WO2012121988A3 Methods for treating diseases using isoindoline compounds |
| 01/10/2013 | WO2012069658A8 Immunomodulatory compositions comprising hydralazine for the treatment of gastrointestinal disorders |
| 01/10/2013 | WO2012018115A9 Composition for regenerating normal tissue from fibrotic tissue |
| 01/10/2013 | US20130012692 Sodium channel blockers |
| 01/10/2013 | US20130012536 Modulators of atp-binding cassette transporters |
| 01/10/2013 | US20130012478 Dosage forms of bisphosphonates |
| 01/10/2013 | US20130011861 Modulators of p-selectin glycoprotein ligand 1 |
| 01/10/2013 | CA2840985A1 Anti-obesity agent comprising high-purity epa |
| 01/10/2013 | CA2840983A1 Adhesive skin patch containing serotonin receptor antagonist drug |
| 01/09/2013 | EP2543390A1 Pharmaceutical composition |
| 01/09/2013 | EP2542545A1 Inhibitors of hepatitis c virus ns5b polymerase |
| 01/09/2013 | EP2542255A1 Methods and compositions for treating degos' disease |
| 01/09/2013 | EP2542235A1 Use of riluzole to treat or prevent the adverse effects of antineoplastic agents |
| 01/09/2013 | EP2542231A1 Novel pharmaceutical composition for the treatment of neurodegenerative or neurovascular diseases |
| 01/09/2013 | EP2542220A2 Use of levodopa, carbidopa and entacapone for treating parkinson's disease |
| 01/09/2013 | EP2542214A1 Cosmetic anti-ageing composition, corresponding use and application method |
| 01/09/2013 | EP2542155A2 Cancer diagnosis and imaging |
| 01/09/2013 | EP2542081A1 Compounds for treatment of cancer |
| 01/09/2013 | EP2542080A1 Treatment of lupus arthritis using laquinimod |
| 01/09/2013 | EP2542074A1 Combination pharmaceutical agents as inhibitors of hcv replication |
| 01/09/2013 | CN102869358A Combination comprising a cyclin dependent kinase 4 or cyclin dependent kinase (cdk4/6) inhibitor and an mtor inhibitor for treating cancer |
| 01/09/2013 | CN102869354A Pharmaceutical comprising myramistin |
| 01/09/2013 | CN102869352A New combination therapy in treatment of oncological and fibrotic diseases |
| 01/09/2013 | CN102861339A Pharmaceutical composition for aerosols with two or more active substances and at least one surfactant |
| 01/09/2013 | CN102861338A Combinations of comprising a bcr-abl, c-kit and pdgf-r tyrosine kinase inhibitor used for treating cancer |
| 01/09/2013 | CN102861337A Egualen sodium containing solid preparation |
| 01/09/2013 | CN102861336A Parenteral nutrition composition containing iron |
| 01/09/2013 | CN102861335A DHEA compositions for treating menopause |
| 01/09/2013 | CN102205126B Application of combined catechin matters together with antibacterial agents |
| 01/08/2013 | US8350076 Sodium channel blockers |
| 01/08/2013 | US8350008 WISP polypeptides and nucleic acids encoding same |
| 01/08/2013 | US8349798 Caveolin peptides and their use as therapeutics |
| 01/08/2013 | US8349353 Controlled release cytotoxic agent compositions and methods for the treatment of otic disorders |
| 01/08/2013 | US8349307 Polymer conjugates of opioid antagonists |
| 01/08/2013 | CA2642665C Anti-cancer pharmaceutical composition |
| 01/08/2013 | CA2544630C Method and material for enhanced tissue-biomaterial integration |
| 01/08/2013 | CA2501201C Gastric acid secretion inhibiting composition |
| 01/08/2013 | CA2485081C Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic |
| 01/08/2013 | CA2478731C Carbamates as hiv protease inhibitors |
| 01/08/2013 | CA2456271C Use of lysyl oxidase inhibitors for cell culture and tissue engineering |
| 01/08/2013 | CA2441577C Therapeutic agents for inflammatory bowel diseases |
| 01/08/2013 | CA2285394C Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases |
| 01/03/2013 | WO2013002365A1 Antipruritic agent |
| 01/03/2013 | WO2013002331A1 Pharmaceutical preparation integrated with microneedles for skin treatment |
| 01/03/2013 | WO2013001449A1 Pharmaceutical compositions containing hydroxypropyl methylcellulose and/or hyaluronic acid and their use |
| 01/03/2013 | WO2012136969A3 Ophthalmic treatments |
| 01/03/2013 | US20130005683 Glycine betaine and its use |
| 01/03/2013 | US20130005608 Yeast screens for treatment of human disease |
| 01/03/2013 | US20130004495 Anti-ngf antibodies for the treatment of various disorders |
| 01/03/2013 | CA2840480A1 Antipruritic agent |
| 01/02/2013 | EP2540316A1 Composition for controlling weight gain and food product containing the same |
| 01/02/2013 | EP2540315A1 Agent for controlling production of primary bile acid and secondary bile acid |
| 01/02/2013 | EP2540302A1 Methods and pharmaceutical compositions for healing wounds |
| 01/02/2013 | EP2540301A2 Methods and pharmaceutical compositions for healing wounds |
| 01/02/2013 | EP2538978A1 Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases |
| 01/02/2013 | EP2538950A1 Zeolite-containing preparations containing clinoptilolite and uses thereof |
| 01/02/2013 | EP2538947A1 Polyimidazoles for use as bile acid sequestrants |
| 01/02/2013 | EP2538945A2 Oral b12 therapy |
| 01/02/2013 | EP2538938A1 Fungal nail treatment composition |
| 01/02/2013 | EP2538937A1 Combination of a centrally-acting analgesic and a selective cyclooxygenase - 2 inhibitor anti - inflammatory agent for the treatment of inflammation and pain in the veterinary field |
| 01/02/2013 | EP2538935A2 Suppression of cancer growth and metastasis using nordihydroguaiaretic acid derivatives with 7-hydroxystaurosporine |
| 01/02/2013 | CN202637537U Rheumatism sticking plaster capable of being pasted on wounded skin surface |
| 01/02/2013 | CN1854157B Antibodies to insulin-like growth factor i receptor |
| 01/02/2013 | CN1454215B Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/02/2013 | CN102858347A Polyimidazoles for use as bile acid sequestrants |
| 01/02/2013 | CN102858339A Combination of a serotonin and norepinephrine reuptake inhibitor and an opioid agonist for the treatment of pain |
| 01/02/2013 | CN102858331A Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina |
| 01/02/2013 | CN102850436A Growth hormone releasing peptides |
| 01/02/2013 | CN102847160A Compound quinolone injection for livestock, and preparation method thereof |
| 01/02/2013 | CN102847159A A glucose metabolism enhancer |
| 01/02/2013 | CN102847158A Traditional Chinese medicine composition paste for treating nephropathy through targeted transferring in renal region and rehabilitation |
| 01/02/2013 | CN102847157A Traditional Chinese medicine composition for treating nephropathy through targeted transferring in renal region |
| 01/02/2013 | CN102847156A Fatty acid synthase inhibitor and application thereof |
| 01/02/2013 | CN102847155A Method for inhibiting tumor metastasis |
| 01/02/2013 | CN102847154A Therapeutic uses of inhibitors of RTP801 |
| 01/02/2013 | CN102847153A Composition for Improving Nutritional Status, Reducing Frequency of Fever and/or Increasing Immunocompetence of the Elderly |
| 01/02/2013 | CN102847152A Inhalation preparation containing N-acetyl-L-cysteine and glucocorticoid, and its preparation method |
| 01/02/2013 | CN102847151A Inhalant preparation containing sodium 2-mercaptoethanesulfonate and glucocorticoid |
| 01/02/2013 | CN102847150A Gene target of aging control and application thereof |
| 01/02/2013 | CN102847149A Methods of treating autoimmune and inflammatory diseases |
| 01/02/2013 | CN102847135A Medicine for reinforcing lymph cycle power to radically cure filarial chyluria, and its use method |
| 01/02/2013 | CN102846868A Application of tibetan medicine RENQINGMANGJUE in preparing antitumor drug |
| 01/02/2013 | CN102247602B Super-molecular hydrogel double-medicament carrier and preparation method as well as application thereof |
| 01/02/2013 | CN102198272B Medicinal composition for promoting fracture union and repairing injured nerves |
| 01/02/2013 | CN101909586B External skin preparation for pimpled skin |
| 01/02/2013 | CN101830889B 嘧啶衍生物 Pyrimidine derivatives |
| 01/02/2013 | CN101827598B Pharmaceutical combination of opioid and prostaglandin compound |
| 01/02/2013 | CN101824090B Monoclonal antibody hpam4 |
| 01/02/2013 | CN101772351B A novel bone mass increasing agent |
| 01/02/2013 | CN101683526B Pharmaceutical composition containing angiotensin II receptor antagonist, B vitamins and gingo biloba extract |
| 01/02/2013 | CN101229164B Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 01/02/2013 | CN101128196B Combination of anticholinergics and leukotriene receptor antagonists for the treatment of respiratory diseases |
| 01/02/2013 | CN101011355B Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof |
| 01/01/2013 | US8344113 Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer |